Age-related macular degeneration (AMD) and glaucoma are degenerative conditions of the
retina and a significant cause of irreversible blindness in developed countries. Alzheimer's …

The dementia population is increasing as the world's population is growing older. The
current systematic review aims to identify digital cognitive biomarkers from computerized …

The user base of the virtual reality (VR) medium is growing, and many of these users will
experience cybersickness. Accounting for the vast interindividual variability in cybersickness …

Background The worldwide prevalence of dementia is rapidly rising. Alzheimer's disease
(AD), accounts for 70% of cases and has a 10–20-year preclinical period, when brain …

Background People with subjective cognitive decline (SCD) may be at increased risk for
Alzheimer's disease (AD). However, not all studies have observed this increased risk. This …

Mild cognitive impairment (MCI) is the prodromal phase of dementia, and it is highly
underdiagnosed in the community. We aimed to develop an automated, rapid (< 5 min) …

Introduction: Motor dysfunction is an important feature of early-stage dementia. Gait provides
a non-invasive biomarker across the dementia continuum. Gait speed and rhythm aid risk …

Background: Many neuroimaging parameters have demonstrated utility as biomarkers in
preclinical AD, including resting-state functional connectivity in the default mode network …

Introduction With 36 million older adult US drivers, safety is a critical concern, particularly
among those with dementia. It is unclear at what stage of Alzheimer's disease (AD) older …

Background Dementia prevalence is predicted to triple to 152 million globally by 2050.
Alzheimer's disease (AD) constitutes 70% of cases. There is an urgent need to identify …